Introduction
Ferroportin (Fpn), the only identified mammalian cellular iron exporter functions as a homodimer 1 hepatocyte iron accumulation [4] [5] [6] [7] . The dominant transmission of both forms is due to a dominant negative effect of the mutant allele on the Fpn dimer 1, 6, 8 . Older patients with mutations in Fpn that should lead to hepatocyte iron loading may also show macrophage iron loading 2, 9 . All human Fpn mutations are missense mutations but the mutations do not predict if a mutant Fpn will exhibit defective trafficking, impaired iron export or hepcidin resistance.
Currently, the only way to determine the effect of mutations in Fpn is to follow trafficking of the protein in cultured cells and to examine the effect of the mutant protein on cellular iron accumulation. Here we show that expression of mutant Fpn in zebrafish offer a rapid approach to identify mutations that lead to macrophage iron retention. We show that the same human mutations that cause macrophage iron retention lead to iron-limited erythropoiesis in zebrafish.
Methods

Maintenance of zebrafish stocks and embryo cultures.
Danio rerio (zebrafish) were maintained at 28.5°C on a 14 hour light/10 hour dark cycle. Wild-type zebrafish were bred and raised according to established procedures approved by the University of Utah Institutional Animal Care and Use Committee. Embryos were collected from natural spawnings, cultured and staged as previously described (Westerfield M, 1993 ).
Injection of Fpn constructs into zebrafish embryos.
Mouse Fpn-GFP constructs were generated as previously described 6, 8 and purified using the EndoFree purification kit (Qiagen, Chatsworth, CA). Approximately 30 to 50 pg DNA was microinjected into zebrafish embryos at the one-cell stage 10 . Embryos at the one cell stage were injected with an iron-dextran solution (100 mg/ml, PIGDEX, American
Cyanamid Co, Princeton, NJ).
Embryo lysates and Western Blot.
Embryos were lysed by homogenizing using a dounce homogenizer in lysis buffer 5 .
Samples were applied to SDS-PAGE using 4-20% gels (Tris-Glycine) (BioRad Laboratories, Hercules, CA) and transferred in Hybond-ECL (Amersham Biosciences, Piscataway. NJ).
Western analysis was performed using rabbit anti-GFP (1:10 000, Abcam #ab6556, Cambridge, MA), followed by peroxidase-conjugated goat anti-rabbit IgG (1:10 000, Jackson
ImmunoResearch Labs, West Grove, PA).
Other procedures.
Staining for erythrocytes was performed by incubating dechorionated (non-fixed)
embryos at 48-72 hpf in an o-dianisidine solution (Sigma, St. Louis, MO)
11
. Embryonic blood at 48-72hpf was stained with Wright-Giemsa or Prussian blue 12 . Peroxidase staining was assayed as an indicator of the endogenous peroxidase activity of hemoglobin. Red blood cells were fixed for 2 minutes with cold methanol and stained with 3,3-diaminobenzidine (DAB) tetrahydrochloride (Sigma, St. Louis, MO) solution 13 . Slides were examined using an Olympus BX51 microscope (Olympus, Tokyo, Japan) using an Olympus U-CMAD-Z camera and a 10X or a 60X/1.3 NA oil immersion objective lens. Images were acquired using Picture Frame 2.5 software (Olympus America, East Muskogee, OK).
Results and Discussion
We investigated the effect of expression of Fpn mutants on erythroid development.
Wild type murine Fpn cDNA, as well as Fpn cDNA containing identified human or murine mutations, were injected into one-cell embryos. Uninjected and injected embryos exhibited similar growth rates and normal morphological development for the first two days. All constructs were expressed at comparable levels as shown by Western blot analysis ( Figure   1A ). There was, however, a difference in the ability of embryos to generate hemoglobinized 4
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From red blood cells depending on the injected construct. Expression of wild type Fpn had no effect on the development of erythrocytes (brown staining denoted by arrow in Figure 1B) but a severe reduction in hemoglobin production was observed in embryos expressing the flatiron mutation (Fpn-GFP H32R) ( Figure 1B) . Mice expressing this Fpn mutation show Kupffer cell iron loading, high serum ferritin and low transferrin saturation. The H32R mutation gives rise to ferroportin disease because H32R Fpn fails to localize to the cell surface and affects the localization of the wild type/mutant heterodimer. Patients heterozygous for the Fpn mutant N174I also show Kupffer cell iron loading. This mutant Fpn is targeted to the cell surface but is transport incompetent. Expression of this mutant Fpn in zebrafish also leads to defective hemoglobinization ( Figure 1B) . In contrast, patients heterozygous for Fpn N144H show hepatocyte iron loading, the result of a transport competent mutant that is unresponsive to hepdicin-mediated internalization 6 . Expression of this mutant Fpn in zebrafish does not impede hemoglobinization ( Figure 1B) . We injected the embryos with iron dextran to determine if we could rescue them from the effect of ironlimitation due to the expression of the mutant protein. Injection of iron dextran had no effect on the survival or hemoglobinization in embryos expressing wild type Fpn-GFP ( Figure 1C) .
In contrast, injection of iron-dextran increased hemoglobinization in embryos expressing Fpn-GFP H32R. Additionally, there was an increase in survival rate and in the size.
The reduced hemoglobinization seen in zebrafish embryos expressing Fpn-GFP H32R
is not due to the absence of red blood cells. Wright-Giemsa staining showed the presence of erythrocytes that appeared morphologically normal, although the size of the nuclei was larger than wild type animals, as would be expected in animals whose red blood cells might be ironlimited (Figure 2A) . Similar results were seen in red blood cells obtained from fish that had been injected with Fpn (N174I). Enlarged nuclei were noted in circulating red blood cells in zebrafish with mutations in the ferroportin or DMT1 genes 14, 15 . To determine if there was a decrease in hemoglobinization, we stained erythrocytes for the presence of heme using diaminobenzidine to assay for hemoglobin peroxidase activity. Wild type erythrocytes showed abundant staining while those from zebrafish expressing Fpn-GFP H32R showed less staining ( Figure 2B) . By visual inspection, all animals appeared to have similar numbers of circulating red blood cells, although small variations (less than 20% would not have been detected). Previously, we showed that the flatiron mouse had a severe iron-limited
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For personal use only. on October 3, 2017. by guest www.bloodjournal.org From erythropoiesis due to a marked reduction in transferrin saturation resulting from defective iron export from macrophages 8 . Circulating red blood cells formed in bullfrog larvae, chicken embryos, and mouse embryos contain large amounts of ferritin containing iron acquired in excess of the need for hemoglobin synthesis 16 . Prussian blue staining detected iron containing deposits, presumably ferritin, in erythrocytes from uninjected zebrafish or zebrafish expressing wild type murine Fpn-GFP (Figure 2C) . Greater than 25% of the red blood cells in wild type zebrafish contained Prussian blue stainable deposits, while in contrast, no Prussian blue deposits were identified in zebrafish expressing Fpn-GFP H32R. These results suggest that the defect in hemoglobin synthesis results from inadequate delivery of iron to the developing erythrocyte. The value of this approach is that an unambiguous determination of Fpn functionality can be made within 24-48 hrs of cDNA injection.
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For personal use only. on October 3, 2017. by guest www.bloodjournal. injected with: wild type constructs was 69.6%, H32R was 50.8% , N144H was 64.7% and N174I 48.2% C. Embryos were injected with wild type or H32R constructs with or without co-injection of iron-dextran. The survival rate of wild type embryos injected with or without iron dextran was 70% with H32R without iron dextran 50% and with iron dextran 62%.
Figure 2 Effect of expression of mutant Fpn on erythroid cell development.
Blood samples from embryos treated as in Figure 1 were stained with Wright-Giemsa (A), diaminobenzidine (B) or Prussian blue (C). The arrow shows iron accumulation in erythrocytes from embryos expressing will type Fpn-GFP but not in embryos expressing Fpn-GFP H32R.
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